FDA Expects OTC Switch Self-Selection Studies To Probe Consumer Thinking

A draft guidance on designing self-selection studies in support of Rx-to-OTC switches reflects FDA’s interest in drilling down for greater insight into consumers’ thought processes.

More from Archive

More from Pink Sheet